scholarly article | Q13442814 |
P356 | DOI | 10.1097/00001756-200410050-00019 |
P698 | PubMed publication ID | 15371741 |
P50 | author | Hilkka Soininen | Q38636823 |
Bengt Winblad | Q66000726 | ||
P2093 | author name string | Xu Li | |
Irina Alafuzoff | |||
Jin-Jing Pei | |||
Wen-Lin An | |||
P433 | issue | 14 | |
P921 | main subject | Alzheimer's disease | Q11081 |
phosphorylation | Q242736 | ||
P304 | page(s) | 2237-2240 | |
P577 | publication date | 2004-10-01 | |
P1433 | published in | NeuroReport | Q15710007 |
P1476 | title | Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain. | |
P478 | volume | 15 |
Q38443497 | Activation of mTOR: a culprit of Alzheimer's disease? |
Q50279747 | Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome. |
Q40955570 | Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model |
Q96431918 | Alzheimer's disease-related dysregulation of mRNA translation causes key pathological features with ageing |
Q53480286 | Biomarker identification for diagnosis of Alzheimer's disease. |
Q37585461 | Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer's disease rats |
Q37180223 | Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease. |
Q38978791 | Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs |
Q34350366 | Elucidating the role of DEPTOR in Alzheimer's disease |
Q33639885 | Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis |
Q40338655 | P70 S6 kinase mediates tau phosphorylation and synthesis |
Q37310632 | PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease |
Q90975119 | Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer's disease |
Q46738279 | Ribosome dysfunction is an early event in Alzheimer's disease. |
Q30394816 | Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease |
Q36173962 | Tau phosphorylation sites work in concert to promote neurotoxicity in vivo |
Q28256247 | The role of mTOR signaling in Alzheimer disease |
Q35016068 | Tumor suppressor PTEN affects tau phosphorylation: deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau. |
Q99238475 | mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in Neurodegeneration |
Q28308319 | mTOR-dependent signalling in Alzheimer's disease |
Q47140692 | mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons |
Search more.